ROCCO, ALBA
 Distribuzione geografica
Continente #
NA - Nord America 2.376
EU - Europa 1.026
AS - Asia 914
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 2
Totale 4.340
Nazione #
US - Stati Uniti d'America 2.340
SG - Singapore 515
CN - Cina 351
IT - Italia 233
IE - Irlanda 225
FI - Finlandia 153
UA - Ucraina 132
NL - Olanda 110
DE - Germania 83
CA - Canada 34
GB - Regno Unito 34
SE - Svezia 33
IN - India 30
CI - Costa d'Avorio 15
VN - Vietnam 13
BE - Belgio 7
EU - Europa 7
PL - Polonia 3
AU - Australia 2
DK - Danimarca 2
ES - Italia 2
MX - Messico 2
RS - Serbia 2
AT - Austria 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
GR - Grecia 1
IQ - Iraq 1
IR - Iran 1
KH - Cambogia 1
LU - Lussemburgo 1
NO - Norvegia 1
NP - Nepal 1
PT - Portogallo 1
TR - Turchia 1
Totale 4.340
Città #
Singapore 426
Chandler 347
Princeton 155
Jacksonville 148
Millbury 140
Nanjing 115
Amsterdam 103
Boston 97
Santa Clara 93
Woodbridge 88
Naples 77
Ashburn 70
Ann Arbor 62
Wilmington 62
Houston 57
Napoli 49
Beijing 46
Nanchang 37
Shenyang 33
Norwalk 32
Ottawa 32
Hebei 26
Falls Church 19
Jiaxing 19
Changsha 16
Tianjin 14
Kronberg 13
Dong Ket 12
Hangzhou 12
Boardman 10
Dearborn 10
Des Moines 9
Qualiano 9
Redmond 9
Dublin 7
Mountain View 7
Orange 7
Washington 7
Kunming 6
New York 6
Pune 6
Rome 6
Santa Maria Capua Vetere 6
Villaricca 6
Milan 5
Munich 5
Zhengzhou 5
Antwerpen 4
Forio 4
Indiana 4
Los Angeles 4
Taizhou 4
Courcelles 3
Eindhoven 3
Formia 3
Fort Worth 3
Jinan 3
Redwood City 3
Rende 3
Belgrade 2
Ciudad Juárez 2
Durham 2
Edinburgh 2
Lanzhou 2
London 2
New Orleans 2
Ningbo 2
Nürnberg 2
San Francisco 2
Tappahannock 2
Terzigno 2
Toronto 2
Walnut 2
Warsaw 2
Afragola 1
Atri 1
Bologna 1
Brno 1
Capri 1
Caserta 1
Catania 1
Chongqing 1
Dalian 1
Dallas 1
Frankfurt am Main 1
Gerocarne 1
Guangzhou 1
Hanoi 1
Hanover 1
Helsinki 1
Italy 1
Kathmandu 1
Lappeenranta 1
Lisbon 1
Little Hampton 1
Lodz 1
Lurago D'erba 1
Madison 1
Madrid 1
Newark 1
Totale 2.623
Nome #
Vascular endothelial growth factor and cyclooxygenase-2 are overexpressed in ileal pouch-anal anastomosis. 166
Large Brunner's gland adenoma: Case report and literature review. 55
Is screening for and surveillance of atrophic gastritis advisable? 54
Vitamin B12 supplementation improves rates ofsustained viral response in patients chronicallyinfected with hepatitis C virus 54
Gastrokine 1 expression in patients with and without Helicobacter pylori infection. 52
Effect of Helicobacter Pylori infection on gastric cell proliferation and genomic instability in a paediatric population of southern Italy. 51
Sweetened carbonated drinks do not alter upper digestive tract physiology in healthy subjects 51
Alcoholic disease: Liver and beyond 50
CD133 and CD44 Cell surface markers do not identify cancer stem cells in primary human gastric tumors 49
Incidence and distribution of coeliac disease in Campania (Italy): 2011-2013 48
Diagnosis of chronic atrophic gastritis by morphometric image analysis. A new method to overcome the confounding effect of the inflammatory infiltrate. 47
Cd133 and Cd44 Cell Surface Markers Do Not Identify Cancer Stem Cells In Primary Human Gastric Tumours 47
Diagnostic accuracy of the serum profile of gastric mucosa in relation to histological and morphometric diagnosis of atrophy 45
Gastro-duodenal lesions and Helicobacter pylori infection in dyspeptic patients with and without chronic renal failure 45
Adenoma carcinoma sequence in the stomach : the role of cycloxygenase-2. 45
C-13-Aminopyrine breath test accurately predicts long-term outcome of chronic hepatitis C 42
BIOINFORMATIC HYPOTHESIS TO PREDICT CLINICALBEHAVIOR AND PROGNOSIS OF GASTRIC CANCER 42
Lactobacillus paracasei F19 versus placebo for the prevention of proton pump inhibitor-induced bowel symptoms: A randomized clinical trial 42
The metabolic role of gut microbiota in the development of nonalcoholic fatty liver disease and cardiovascular disease 42
Helicobacter pylori and epigenetic mechanisms underlying gastric carcinogenesis. 41
Risk factors in gastric cancer 41
A RAT MODEL OF OXIDATIVE AND METABOLIC HEPATIC INJURY: THE POTENTIAL PROTECTIVE ROLE OF LACTOBACILLUS PARACASEI F19 41
13c-aminopyrine breath test: a sentitive and reliable method to discriminate the early stage of liver cirrhosis 41
Effects of long-term PPI treatment on producing bowel symptoms and SIBO 40
Effect of Helicobacter Pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis. 39
Gastric adenomas: relationship between clinicopathological findings, Helicobacter pylori infection, APC mutations and COX-2 expression. 38
Review article: helicobacter pylori and molecular events in precancerous gastric lesions. 38
In vivo and in vitro studies of cytosolic phospholipase A2 expression in Helicobacter pylori infection. 38
Loss of expression of tumor suppressor p16(INK4) protein in human primary gastric cancer is related to the grade of differentiation. 37
Age-specific prevalence of Helicobacter pylori infection and morphological findings of gastric mucosa. A retrospective study in a symptomatic pediatric population of southern Italy. 37
CHEMOPREVENTION OF GASTRIC CANCER: ROLE OF COX-2 INHIBITORS AND OTHER AGENTS 36
Reflux oesophagitis in adult coeliac disease: beneficial effect of a gluten free diet. 36
Interleukin-13 mucosal production in Helicobacter pylori-related gastric diseases. 36
Expression of COX-2, mPGE-synthase1, MDR-1 (P-gp), and Bcl-xL: a molecular pathway of H pylori-related gastric carcinogenesis. 36
An unusual case of high alpha-fetoprotein level and liver masses. 36
13C-Aminopyrine breath test discriminates the early stages of liver cirrhosis 36
The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract. 35
Protective effects of Lactobacillus paracasei F19 in a rat model of oxidative and metabolic hepatic injury 35
The proliferation marker Chromatin Assembly Factor-1 is of clinical value in predicting the biological behaviour of salivary gland tumours. 35
13C-AMINOPYRINE BREATH TEST PREDICTS THE CLINICAL OUTCOME IN PATIENTS WITH C VIRUS-RELATED CHRONIC HEPATITIS 35
Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: An ex-vivo organ culture model of post-infectious irritable bowel syndrome 35
Diet, H pylori infection and gastric cancer: evidence and controversies. 34
Molecular alteration of gastric carcinoma. 34
Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease 34
Acquisition of Helicobacter pylori infection in childhood: a risk for gastric carcinogenesis 34
Cell proliferation, apoptosis and DNA-ploidy of gastric mucosa in Helicobacter pylori infection 34
Is there a link between environmental factors and a genetic predisposition to cancer? A lesson from a familial cluster of gastric cancers. 33
Mdr1 P-glycoprotein expression in human gastric tissue: From ontogenesis to carcinogenesis 33
Does Helicobacter Pylori play a role in inflammatory bowel disease? 32
Gastric atrophy and intestinal metaplasia changes 8 years after Helicobacter pylori eradication. A blind, randomised study. 32
Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial. 32
Does the cytokine response in chronic HCV-infected subjects predict the outcome of the infection ? 32
Cox-2 and NF-KB expression in gastric mucosa is influenced by peroxisome proliferator –activated receptor-gamma polymorphisms. 32
Atrophic gastritis and intestinal metaplasia reversibility after Helicobacter pylori eradication: a long term follow-up 32
Tissue ghrelin level and gastric emptying rate in adult patients with celiac disease. 31
P-gp regulates apoptosis in gastric mucosa by interacting with bcl-xL: an in vivo and in vitro study 31
Cell proliferation and genomic instability in chronic gastritis, with and without Helicobacter pylori infection, and in gastric cancer. 31
Tissue Ghrelin Level Does Not Correlate With Gastric Emptying Rate In Adult Coeliac Patients. 30
GASTRIC CANCER BIOLOGICAL BEHAVIOUR: FROM BIOINFORMATIC HYPOTHESIS TO MOLECULAR ANALYSIS 30
Gastrokine 1 in Helicobacter pylori-related gastric carcinogenesis: A genomic, proteomic, and immunohistochemical study 30
Overexpression of chromatin assembly factor-1 p60, poly(ADP-ribose) polymerase 1 and nestin predicts metastasizing behaviour of oral cancer. 30
Increased severity of dyspeptic symptoms related to mental stress is associated with sympathetic hyperactivity and enhanced endocrine response in patients with postprandial distress syndrome 30
Cyclo-oxygenase-2 and P-glycoprotein expression in gastric cancer: a possible pathway of multidrug resistance 29
Cancer stem cell hypothesis and gastric carcinogenesis: Experimental evidence and unsolved questions 29
Gluten free diet significantly decreases adiponectin serum levels in adult celiac disease patients 28
C-kit protein expression in Wilms' tumour: an immunohistochemical study. 28
Long acting release-octreotide as "rescue" therapy to control angiodysplasia bleeding: A retrospective study of 98 cases 28
The Gut Bacteria-Driven Obesity Development 28
The gut microbiota: A new potential driving force in liver cirrhosis and hepatocellular carcinoma 28
Gastrokine 1 in Helicobacter pylori-related gastric carcinogenesis: A genomic, proteomic, and immunohistochemical study 27
Up-regulation of heparin binding epidermal growth factor-like growth factor and amphiregulin expression in Helicobacter pylori-infected human gastric mucosa. 27
P-gp protects gastric mucosa from apoptosis by interacting with bcl-xL: an in vivo and in vitro study 27
Cyclo-oxygenase-2 and P-Glycoprotein expression in gastric cancer: a possible pathway of multidrug resistance. 27
Screening for and surveillance of gastric cancer 27
I livelli tessutali di grelina non correlano con il tempo di svuotamento gastrico 26
Relationship between genomic instability markers and Helicobacter pylori infection in gastric carcinogenesis 26
Angiodysplasia as a possible cause of gastrointestinal bleeding in cirrhosis and octreotide treatment. 26
Changes of protein expression in Helicobacter pylori-infected human gastric mucosa 26
Does the local cytokine response in Helicobacter pylori infected subjects predict the outcome of infection ? 25
Down-regulation of human Gastrokine 1 isoforms in Helicobacter pylori-related gastric carcinogenesis 25
VITAMIN B12 SUPPLEMENTATION IMPROVES SUSTAINED-VIRAL-RESPONSE RATES IN HEPATITIS C VIRUS GENOTYPE 1B-INFECTED PATIENTS 25
VITAMIN B12 SUPPLEMENTATION IMPROVES SUSTAINEDVIRAL-RESPONSE RATES IN HEPATITIS C VIRUS-INFECTEDPATIENTS 25
Gastric Emptying Time, Esophageal pH-Impedance Parameters, Quality of Life, and Gastrointestinal Comorbidity in Obese Children and Adolescents 25
Probiotics: a potential target for the prevention and treatment of steatohepatitis. 24
Histological heterogeneity and somatic mtDNA mutations in gastric intraepithelial neoplasia. 24
NF-KB modulation and anti-apoptotic effects of IL-13 in gastric adenocarcinoma epithelial cell lines 24
Increased mucosal nitric oxide production in ulcerative colitis is mediated in part by the enteroglial-derived S100B protein. 24
Global DNA hypomethylation is an early event in Helicobacter pylori-related gastric carcinogenesis. 24
Efficacy of 5-Day Levofloxacin-Containing Concomitant Therapy in Eradication of Helicobacter pylori Infection 24
Gastrokine 1 expression in patients with and without Helicobacter pylori infection 24
The effects of interleukin (IL)-13 on NF-kB-related cytokine profile and cell viability in "in vitro" model 23
Validation of gastric hormone profile in the diagnosis of gastric atrophy by Receiving Operatine Characteristic (ROC) curve analysis 23
Gastric carcinogenesis mirrors stomach ontogenesis: expression of P-glycoprotein in human gastric tissue 23
MDR1-P-glycoprotein expression in human gastric tissue from ontogenesis to carcinogenesis 23
DNA HYPOMETHYLATION IS AN EARLY EVENT IN HP-RELATED GASTRIC CARCINOGENESIS 23
Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates. 22
Helicobacter pylori and MDR1 P-glycoprotein expression in human gastric tissue: from ontogenesis to carcinogenesis 22
IDENTIFICATION AND CHARACTERIZATION OF CANCER STEM CELLS IN PRIMARY HUMAN GASTRIC CANCER 22
Gastric emptying time and prevalence of small intestinal bacterial overgrowth in newly diagnosed celiac disease patients 22
Gastric atrophy and intestinal metaplasia reversibility after Helicobacter pylori eradication: a long term follow-up 22
Totale 3.475
Categoria #
all - tutte 20.963
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.963


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020232 0 0 0 0 46 12 19 3 0 52 54 46
2020/2021290 1 30 28 27 32 68 27 2 33 3 26 13
2021/2022864 4 0 0 11 0 24 3 26 233 63 155 345
2022/2023858 162 61 16 72 91 111 2 76 116 106 39 6
2023/2024527 24 80 104 45 23 37 10 40 3 6 115 40
2024/2025691 212 296 15 44 124 0 0 0 0 0 0 0
Totale 4.498